source
- Third Rock partner’s brain cancer diagnosis highlights personal impact of biotech drug developmentJigar Raythatha, a partner at Third Rock Ventures, was diagnosed with a rare form of brain cancer in 2023 after a routine MRI. On the same day his diagnosis was confirmed, Servier announced posit…
- Genmab shares jump as petosemtamab plus Keytruda halves death risk in head-neck cancer trialGenmab reported that a late-stage study of its experimental antibody petosemtamab combined with Keytruda cut the risk of death by about 50 percent compared with Keytruda alone in patients with PD‑L…